{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:35:10Z","timestamp":1792697710867,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.forsciint.2021.110884","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T11:01:29Z","timestamp":1624705289000},"page":"110884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Simultaneous LC-MS\/MS screening for multiple phenethylamine-type conventional drugs and new psychoactive substances in urine"],"prefix":"10.1016","volume":"325","author":[{"given":"Shu-Yu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Zong","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Han","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hsiang","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2021.110884_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","article-title":"2C or not 2C: phenethylamine designer drug review","volume":"9","author":"Dean","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110884_bib2","unstructured":"United Nations Office on Drugs and Crime, World Drug Report 2020: Cross-Cutting Issues: Evolving Trends and New Challenges. United Nations publication, Division for Policy, Analysis and Public Affairs, United Nations, Austria. Available at: \u3008https:\/\/wdr.unodc.org\/wdr2020\/field\/WDR20_BOOKLET_4.pdf\u3009."},{"key":"10.1016\/j.forsciint.2021.110884_bib3","first-page":"172","article-title":"DART-MS in source collision induced dissociation and high mass accuracy for new psychoactive substance determinations","volume":"9","author":"Musah","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110884_bib4","series-title":"Encyclopedia of Behavioral Neuroscience","article-title":"Psychostimulants","author":"Koob","year":"2010"},{"key":"10.1016\/j.forsciint.2021.110884_bib5","series-title":"Critical Issues in Alcohol and Drugs of Abuse Testing","first-page":"247","article-title":"Chapter 20 \u2013 New psychoactive substances: an overview","author":"Mercolini","year":"2019"},{"key":"10.1016\/j.forsciint.2021.110884_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108045","article-title":"Drinking to death: hyponatraemia induced by synthetic phenethylamines","volume":"212","author":"Faria","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2021.110884_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.forsciint.2021.110884_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1586\/17512433.2016.1167597","article-title":"Novel psychoactive substances: the pharmacology of stimulants and hallucinogens","volume":"9","author":"Schifano","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2021.110884_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.1570","article-title":"New phenethylamines in Europe","volume":"6","author":"King","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.110884_bib10","series-title":"Addictive Substances and Neurological Disease","first-page":"341","article-title":"Novel psychoactive substances","author":"Zanda","year":"2017"},{"key":"10.1016\/j.forsciint.2021.110884_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4155\/bio-2020-0148","article-title":"Recent bionalytical methods for the determination of new psychoactive substances in biological specimens","volume":"12","author":"Sim\u00e3o","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.forsciint.2021.110884_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/NRL.0b013e3181a3cb53","article-title":"Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion","volume":"16","author":"Ambrose","year":"2010","journal-title":"Neurologist"},{"key":"10.1016\/j.forsciint.2021.110884_bib13","doi-asserted-by":"crossref","first-page":"1843.e1","DOI":"10.1016\/j.ajem.2015.04.065","article-title":"Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series","volume":"33","author":"Hieger","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.forsciint.2021.110884_bib14","first-page":"78","article-title":"Analysis of amphetamine-derived designer drugs by gas chromatography with mass spectrometry","volume":"40","author":"Ondra","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110884_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chroma.2012.12.049","article-title":"New challenges and innovation in forensic toxicology, focus on the \u201cnew psychoactive substances\u201d","volume":"1287","author":"Favretto","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2021.110884_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1570-0232(01)00619-5","article-title":"Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography\u2013mass spectrometry","volume":"773","author":"Staack","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2021.110884_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jat\/25.5.333","article-title":"The antispasmodic drug mebeverine leads to positive amphetamine results by fluorescence polarization immunoassay (FPIA)\u2013studies on the toxicological analysis of urine by FPIA and GC\u2013MS","volume":"25","author":"Kraemer","year":"2001","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110884_bib18","series-title":"Encyclopedia of Separation Science","first-page":"448","article-title":"Chromatography: gas detectors: mass spectrometry","author":"Clench","year":"2000"},{"key":"10.1016\/j.forsciint.2021.110884_bib19","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/164_2017_83","article-title":"Bioanalytical methods for new psychoactive substances","author":"Wagmann","year":"2018"},{"key":"10.1016\/j.forsciint.2021.110884_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/dta.306","article-title":"Development of a rapid LC-MS\/MS method for direct urinalysis of designer drugs","volume":"3","author":"Bell","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.110884_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jchromb.2014.08.033","article-title":"Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS\/MS","volume":"969","author":"Tang","year":"2014","journal-title":"\u200eJ. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2021.110884_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.legalmed.2016.02.006","article-title":"GC-PCI-MS\/MS and LC-ESI-MS\/MS database for the detection of 104 psychotropic compounds (synthetic cannabinoids, synthetic cathinones, phenethylamine derivatives)","volume":"20","author":"Waters","year":"2016","journal-title":"Leg. Med."},{"key":"10.1016\/j.forsciint.2021.110884_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.forc.2017.12.007","volume":"7","author":"Dziadosz","year":"2018","journal-title":"Forensic Chem."},{"key":"10.1016\/j.forsciint.2021.110884_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jat\/bkaa103","article-title":"A comprehensive HPLC\u2013MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid","volume":"44","author":"Di Trana","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110884_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific working group for forensic toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2021.110884_bib26","unstructured":"Laboratory and Scientific Section of the United Nations Office on Drugs and Crime, Guidance for the Validation of Analytical Methodology and Calibration of Equipment used for Testing of Illicit Drugs in Seized Materials and Biological Specimens, United Nations Office on Drugs and Crime, 2009. Available at: \u3008https:\/\/www.unodc.org\/documents\/scientific\/validation_E.pdf\u3009."},{"key":"10.1016\/j.forsciint.2021.110884_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chroma.2015.04.002","article-title":"Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography\u2013high resolution mass spectrometry and library matching","volume":"1397","author":"Concheiro","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2021.110884_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpba.2016.07.009","article-title":"A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC\u2013MS\/MS and application to real cases","volume":"129","author":"Vaiano","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2021.110884_bib29","unstructured":"Ministry of Health and Welfare, The Annual of Statistical Data of Cases and Laboratory Examinations for the Drug Abuse 2019: Taiwan Food and Drug Administration, Ministry of Health and Welfare, 2019."},{"key":"10.1016\/j.forsciint.2021.110884_bib30","unstructured":"Analytic Laboratory Urine and Drug Abuse Report System of Taiwan, Report of NPS Detected in Taiwan. Available at: \u3008http:\/\/www.fda.gov.tw\/tc\/includes\/GetFile.ashx?id=f637499375526616067\u3009. (Accessed December 2020)."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073821002048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073821002048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:08:10Z","timestamp":1759946890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073821002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S0379073821002048"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.110884","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous LC-MS\/MS screening for multiple phenethylamine-type conventional drugs and new psychoactive substances in urine","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.110884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110884"}}